This Solicitation opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
LIDOCAINE, PATCH
Closed
SPE2DP-26-T-3470FederalSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Show more
This contract pertains to the procurement of lidocaine adhesive patches, each containing 700 mg of lidocaine (5% strength) in an aqueous base, intended for prescription use to relieve pain associated with post-herpetic neuralgia. The patches measure 10 cm by 14 cm and are designed for cutaneous application on intact skin, with a maximum of three patches applied once for up to 12 hours within a 24-hour period. The product is packaged in units of 30 individually sealed patches per carton, stored at controlled room temperature, and must be kept dry to maintain adhesion. The contract specifies that labeling and marking conform to Medical Marking Standard No. 1C, and the product is regulated by the FDA. The contract includes detailed compliance requirements regarding hazardous material communication in accordance with OSHA’s Hazard Communication Standard and Federal Standard No. 313-E, ensuring submission of Safety Data Sheets and proper hazardous material labeling. Packaging must protect against damage, adhere to commercial standards, and meet specified marking and palletization requirements. The contract calls for delivery within 20 days at Fort Bragg, North Carolina, with four packages ordered. Inspection and acceptance are at destination, and all shipping must be traceable with no parcel post used. The procurement is managed by the Department of Defense Medical Supply Chain, with a designated point of contact for questions and coordination.
General Info
Procurement of FDA-regulated lidocaine patches, 700 mg, 5%, delivered to Fort Bragg within 20 days.
Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
NAICS
424210 - Drugs and Druggists' Sundries Merchant Wholesalers View NAICS
Place of Performance
5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USSet-Aside
NONE
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS
Contacts
Full Description
Show more
LIDOCAINE,PATCH
LIDOCAINE,PATCH.
RX ONLY. EACH ADHESIVE PATCH CONTAINS 700 MG
OF LIDOCAINE (50 MG PER GRAM ADHESIVE) IN AN
AQUEOUS BASE. INDICATED FOR RELIEF OF PAIN
ASSOCIATED WITH POST-HERPETIC NEURALGIA. IT
SHOULD BE APPLIED ONLY TO INTACT SKIN. APPLY
LIDOCAINE PATCH 5% TO INTACT SKIN TO COVER
THE MOST PAINFUL AREA. APPLY THE PRESCRIBED
NUMBER OF PATCHES (MAXIMUM OF 3), ONLY ONCE
FOR UP TO 12 HOURS WITHIN A 24-HOUR PERIOD.
PATCH SIZE 10 CM × 14 CM, ROUTE OF
ADMINISTRATION CUTANEOUS, DOSE FORM ADHESIVE
PATCH, MEDICATED STRENGTH 5 %;700 MG OVER
12 HOURS
.
UNIT OF ISSUE IS A PACKAGE (OR CARTON)
CONTAINING 30 EACH (INDIVIDUALLY SEALED
PATCHES OR CHILD-RESISTANT ENVELOPES).
.
STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP
CONTROLLED ROOM TEMPERATURE]. LIDOCAINE
PATCH 5% MAY NOT STICK IF IT GETS WET.
AVOID CONTACT WITH WATER, SUCH AS BATHING<(>,<)>
SWIMMING OR SHOWERING.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1C.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
SPE2DP-26-T-3470
SECTION B
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00591-3525-30 AVKARE LLC 4QGW8 P/N NDC42291-0495-30 GSMS INC 7A8G1 P/N NDC51407-0827-30 AMNEAL PHARMACEUTICALS OF NEW YORK, LLC 557X3 P/N NDC65162-0791-08 YARAL PHARMA INC 9D9C5 P/N NDC82347-0505-05
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3470
SECTION B
PR: 7016815570 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016815570 0001 PG 4.000
NSN/MATERIAL:6505016572003
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
SPE2DP-26-T-3470
SECTION B
PR: 7016815570 PRLI: 0001 CONT’D
US
M/F: (TCN) W91KBP61340276
RDD: 148
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/20/2026
SPE2DP-26-T-3470 NSN/Part Number: 6505-01-657-2003 Quantity: 4 PG Purchase Request: 7016815570QTY: 4 Delivery: 20 days ADO
LIDOCAINE,PATCH.
RX ONLY. EACH ADHESIVE PATCH CONTAINS 700 MG
OF LIDOCAINE (50 MG PER GRAM ADHESIVE) IN AN
AQUEOUS BASE. INDICATED FOR RELIEF OF PAIN
ASSOCIATED WITH POST-HERPETIC NEURALGIA. IT
SHOULD BE APPLIED ONLY TO INTACT SKIN. APPLY
LIDOCAINE PATCH 5% TO INTACT SKIN TO COVER
THE MOST PAINFUL AREA. APPLY THE PRESCRIBED
NUMBER OF PATCHES (MAXIMUM OF 3), ONLY ONCE
FOR UP TO 12 HOURS WITHIN A 24-HOUR PERIOD.
PATCH SIZE 10 CM × 14 CM, ROUTE OF
ADMINISTRATION CUTANEOUS, DOSE FORM ADHESIVE
PATCH, MEDICATED STRENGTH 5 %;700 MG OVER
12 HOURS
.
UNIT OF ISSUE IS A PACKAGE (OR CARTON)
CONTAINING 30 EACH (INDIVIDUALLY SEALED
PATCHES OR CHILD-RESISTANT ENVELOPES).
.
STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP
CONTROLLED ROOM TEMPERATURE]. LIDOCAINE
PATCH 5% MAY NOT STICK IF IT GETS WET.
AVOID CONTACT WITH WATER, SUCH AS BATHING<(>,<)>
SWIMMING OR SHOWERING.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1C.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
SPE2DP-26-T-3470
SECTION B
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00591-3525-30 AVKARE LLC 4QGW8 P/N NDC42291-0495-30 GSMS INC 7A8G1 P/N NDC51407-0827-30 AMNEAL PHARMACEUTICALS OF NEW YORK, LLC 557X3 P/N NDC65162-0791-08 YARAL PHARMA INC 9D9C5 P/N NDC82347-0505-05
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-3470
SECTION B
PR: 7016815570 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016815570 0001 PG 4.000
NSN/MATERIAL:6505016572003
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
SPE2DP-26-T-3470
SECTION B
PR: 7016815570 PRLI: 0001 CONT’D
US
M/F: (TCN) W91KBP61340276
RDD: 148
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/20/2026
SPE2DP-26-T-3470 NSN/Part Number: 6505-01-657-2003 Quantity: 4 PG Purchase Request: 7016815570QTY: 4 Delivery: 20 days ADO